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June 1985
Public Policy Implications of Declining Old-Aqe Mortality
ABSTRACT
This paper explores some policy implications of declining mortality among
the elderly population. There are two views of how health progress will affect
the social burden of caring for the aged. One holds that prolonging the lives
of frail individuals will result in rapidly increasing medical and other costs
per aged person. A second view suggests that health progress and behavioral
changes will reduce both mortality and morbidity rates, lowering the average
cost per person of caring for the aged. This paper investigates recent trends
in the health status of the elderly to distinguish between these two views. The
findings suggest that reductions in morbidity and mortality have been roughly
counterbalanced by the rising frailty of the surviving population. Age specific
institutionalization rates and medical cost patterns have been relatively stable
for the last two decades, suggesting neither dramatic improvements nor sharp
reductions in the health status of the elderly.

-2-
Recent years have witnessed dramatic improvements in the longevity of
the elderly population. Life expectancy for women at age 65 increased by 3.3
years, a 22 percent change, between 1950 and 1980. Age-specific death rates
fell by 29 percent for the over-85 female population, and by 19 percent for
over-85 males. Continuation of these trends could have major implications for
public policy towards the elderly. If mortality rates continue to drop, the
elderly population will be substantially larger than if mortality rates remain
constant at their current level. The number of extreme elderly, those over age
85, could rise especially rapidly.
This paper explores some policy implications of the dramatic longevity
gains which have occurred, and which are likely to occur in the future. We
focus on the potential burden, through demand for medical care and other resour-
ces, which the elderly are likely to create. Different views on this issue are
possible. A pessimistic outlook would hold that improvements in life expectancy
are likely to be associated with large increases in the costs of supporting the
elderly. The elderly will grow more numerous particularly at very old ages
where support costs are greatest. These costs may be particularly high for
"marginal survivors" — those who would have died at earlier ages but for recent
progress in reducing mortality. A more optimistic view is also possible. It
would argue that the same forces which have led to recent declines in mortality
might also be expected to lead to declining morbidity and increased ability to
function. Mortality reductions lower the number of the aged who are within a
year or two of death. Since these are the years when support costs are highest.
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especially for health care, the social burden per aged person might actually
decline.
The relative importance of these two effects is an empirical question
which cannot be resolved by a priori argument. Which view is more appropriate
is, however, clearly an important policy issue. Projections of future Medicare
costs are extremely sensitive to the number and expected needs of potential
beneficiaries. While much attention has focused on efforts to reduce Medicare
costs by reforming reimbursement procedures and changing the health care deli-
very system, there are limits to the savings available from these devices.
Moreover, their fundamentally one-shot character makes their impact on projected
future costs much smaller than demand-related factors such as health status
which cumulate year after year.
This paper surveys some relevant evidence, and presents some new
calculations, bearing on the effects of mortality improvements. While the
available data permit only tentative conclusions, it appears that reductions in
morbidity associated with declining mortality have been counterbalanced by high
morbidity rates among marginal survivors. As a consequence, the health needs of
elderly persons at given ages have not changed very much.
The paper is divided into five sections. The first analyzes recent
trends in mortality among the aged. We document the substantial changes which
have occurred in both mortality rates and life expectancy, and consider projec-
tions of further progress in reducing the mortality of the elderly. We show
that a sizable fraction of the elderly population, particularly at extreme
ages, is comprised of "marginal survivors."
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The second section presents a formal model capable of capturing the
various effects of health progress on the elderly population. It allows a role
for both population heterogeneity and health progress in reducing morbidity,
and provides a basis for understanding both the optimistic and pessimistic
views. We use the model to examine the effects of recent mortality progress.
Using demographic data for the population cohorts born between 1880 and 1910, we
find little support for the "life table rectangularization" hypothesis. Rather,
progress in reducing mortality is if anything an increasing function of age.
The third section considers several types of evidence on the age-
specific health status of the elderly to distinguish between the optimistic and
pessimistic views. Since health is many-faceted, we employ several different
measures of health status. The recent evolution of age-specific Medicare costs,
institutionalization rates, and disability suggests that the effects of addi-
tional survivorship have been about as large as those of reduced morbidity.
Continuation of this balance implies that the future aging of the elderly popu-
lation is likely to be associated with modest increases in per-capita health
care costs. Medical costs are higher for the very old than for those in their
sixties and seventies, and the increasing proportion of the elderly who will be
in their eighties will tend to raise average expenditures per person over age
65. However, there is little evidence to suggest that age-specific costs are
likely to increase substantially.
The fourth section examines some micro-econometric evidence bearing on
these issues. We analyze data from the Longitudinal Retirement History Survey.
Although the data sample is limited by the absence of anyone over the age of 73,

the LRHS can still shed some light on the two views. We show that even
controlling for time until death, age has a substantial effect on rates of
retirement and medical costs. This confirms our judgement that the observed
relationship between age and morbidity, and age and medical costs, is not a
spurious one due solely to an underlying link between health status and time
till death. Our conclusion considers the policy implications of our findings,
and suggests several directions for future research.

I. Mortality Trends among the Aged
I. A. Historical Experience
The last several decades have witnessed dramatic reductions in mor-
tality among the aged. Life expectancy for women at age 65, after rising by 1.8
years between 1950 and 1970, has risen by 1.5 years between 1970 and 1980. For
men, the change between 1950 and 1970 was 0.2 years, while the 1970-80 period
saw a 1.1 year increase in life expectancy at age 65. These increases in
life expectancy were caused by dramatic reductions in mortality rates at all
ages. Between 1950 and 1980 the death rate of male 85 year olds fell from
221 per thousand to 178 per thousand, or nearly twenty percent.
Table 1 describes progress in reducing mortality among the aged over
the past forty years. We present data on white men and white women, because
demographic data for nonwhites at extreme ages are somewhat unreliable.! Several
patterns emerge from the mortality data. First, mortality gains have been
greater for women than for men, despite convergence between the sexes in pat-
terns of employment, lifestyle, and rates of smoking. Second, about equal per-
centage mortality gains have occurred at all ages. If anything, the gains have
been greater among the very old than among those aged 55 to 75. Despite fore-
casts of ultimate limits on life expectancy and the rectangularization of the
life table, there is no evidence of rising mortality rates as more and more
people reach extreme ages. The fragmentary available evidence on mortality
rates among those over 90 also supports this conclusion, 2 Third, the pace of
mortality reductions has accelerated, with especially rapid progess being made
during the 1970's.

Year
1950
1960
1970
1980
Year
1950
1950
1970
1980
Year
1950
1960
1970
1980
Year
1950
1950
1970
1980
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Table 1
Historical Reductions in Mortality
and Gains in Life Expectancy
Crude Death Rates (per 1000 persons)
WHITE MEN
Aae 55-59 Aqe 65-69 Aqe 75-79 Aqe 85+
18.8 40.7 90.1 221.2
17.8 40.5 87.0 217,5
17.7 40.5 85.9 185.5
13.9 33.2 80.7 178.2
WHITE WOMEN
Aqe 55-59 Aqe 65-59 Aqe 75-79 Aqe 85+
10.2 25.2 69.9 196.8
B.S' 21.5 60.8 194.8
8.3 19.2 53.5 159.8
7.2 15.5 45.5 140.4
Life Expectancies
WHITE MEW
Aqe 55 Aqe 65 Aqe 75 Aqe 85
19 .
1
12.8 7.8 4.4
19.5 13.0 7.9 4.4
19.5 13.0 8.1 4.5
21.2 14.2 8.3 5.0
WHITE WOMEN
Aqe 55 Aqe 55 Aqe 75 Aqe 35
22.6 15.0 3.9 4.8
23.8 15.9 9.3 4.7
24.9 16.9 10.2 5.5
25.5 18.5 11.5 5.3
Notes: Death rates are drawn from U.S. Public Health Service, Vital Statistic
of the United States, Volume II -- Mortality, Part A, for various
years. Life expectancies are from Vital Statistics of the United
States, 1980, Life Tables, Volume II, Section 5 .

The second part of the table illustrates the substantial changes in
life expectancy during this period. For women aged 75, life expectancy
increased from 8.9 to 11.5 years between 1950 and 1980, an increase of 29 per-
cent. The gain for men at age 75 was only one year during this period. Even at
age 85, there were dramatic improvements: a 14 percent increase for men, and a
31 percent gain for women. In 1950, an 85-year-old woman's life expectancy was
only 0.4 years greater than that for an 85-year-old man. In 1980, the dif-
ference was 1.5 years.
The causes of these dramatic declines in mortality are not well
established. The bulk of the increase in life expectancy at older ages appears
to be the result of reductions in mortality rates from cardiovascular diseases.
The most recent report of the Social Security Actuary-^ indicates that between
1968 and 1980, mortality from heart disease among persons 65-69 declined at a
2.9 percent annual rate, and mortality from vascular disease fell at a 5.0 per-
cent rate. Partially reflecting these changes, cancer death rates actually rose
at a .5 percent annual rate over the same interval.
The cause of these mortality reductions is far from clear. One
possible explanation is improvements in access to medical care due to the enact-
ment of Medicare and Medicaid in 1965. The timing of the acceleration in the
decline in mortality rates supports this possibility. An alternative possibi-
lity is improvements in medical procedures for treating hypertension and heart
attacks. Still another possible cause of the decline is improvements in diet
and exercise among the aged. In all likelihood the decline in mortality can be
traced to some combination of all these factors.
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Declines in mortality have potentially important effects on the com-
position of the aged population. Most obviously, the average age of the elderly
population will increase as more and more people survive to older ages. More
subtly but probably more importantly, reduced mortality means that the popula-
tion at any given age will include marginal survivors who will be less healthy
and less self sufficient than the remainder of the population.
The magnitude of the mortality declines is well conveyed by the infor-
mation in Table 2. The table presents estimates of the fraction of 1980 popula-
tion at various ages who, conditional upon reaching age 50, would not have been
alive had they faced the mortality rates of cohorts born 10, 20, 30 or 40 years
earlier. We focus on persons who would have reached age 50 to highlight changes
for the elderly, and to avoid contaminating our results with changes in infant
mortality or other factors affecting younger persons.
The shares of "marginal survivors" are calculated using cohort life
tables for persons born in the first year of each decade between 1850 and 1910.^
These data should be distinguished from those in synthetic life tables, the
type commonly used in calculations of life expectancies. In a synthetic table
for year t, the death rates at each age correspond to the probability that a
person of that age would die in year t. The death rates for each age therefore
correspond to different birth cohorts. In a cohort life table, a single birth
cohort is followed throughout its life.
We calculated the number of marginal survivors as follows. Let q
denote the probability that a person born in year k dies between birthdays t and
t+1, conditional on living to age t. The probability of living to age t in
birth cohort k, conditional on reaching age 50, is therefore
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Table 2
The Importance of Marginal Survivors: 1930
Fraction of Persons Alive in 1980 Who Would
Not Have Been Alive if Born m Years Earlier
WHITE MEN
Number of
Years Born
Earl ier (m) Aqe SO Aqe 70 Aqe 80 Aqe 90
10 .039 .034 .050 .162
20 .038 .060 .080 .363
30 .054 .085 .151 .584
40 .065 .105 .251 .587
WHITE WOMEN
Age 50 Age 70 Age 80 Aqe 90
.00^ .029 .108 .304
.014 .080 .222 .530
.036 .144 .351 .723
.061 .207 .462 .752
10
20
30
40
Sources: Authors' calculations based on mortality rates provided by
Metropolitan Life Insurance Company, and supplemented with data from
the Vital Statistics of the United States, Volume II-Mortality, Part
A, for years since 1974.
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s^it) = n (i-q":).
i=50
For persons of age a in 1980, a fraction S ^(a) of the members of the birth
cohort who reached age 50 are still alive. If these persons had been born m
years earlier, the comparable fraction would have been S "^""^(a). The proportion
of the 1980 population which is accounted for by marginal survivors relative to
the cohort m years earlier, MS(a,m), is therefore:
The results of these calculations are shown in Table 2. Particularly
at old ages, the share of marginal survivors in the population is very high.
Fifteen percent of the 80 year old men alive in 1980, and thirty-five percent of
the 80 year old women, would have reached age 50 but not have been alive at 80
given the mortality experience of the cohort that preceded them by 30 years.
The share of marginal survivors rises rapidly with age. For women at age 60, it
is only 0.9 percent, rising to 2.9 percent at age 70, 10.8 percent at 80, and
then at a rate of about 4 percentage points per year for each year in the
eighties.
The dramatic importance of marginal survivors at extreme ages may be
somewhat misleading, since the number of individuals alive at these ages is much
smaller than those at earlier ages. We therefore calculated the fraction of the
over-50 population which would not have been alive if everyone had faced the
life table of the cohort thirty years before them. Over nine percent of the
men and 16.9 percent of the women over age 60 in 1980 were marginal survivors.
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If people had faced the life table of those born 40 years earlier, twelve per-
cent of the men and twenty-two percent of the women would not have reached their
current ages.^
Changes in mortality rates or other indicators of health status for
the very old are difficult to interpret. The composition of the population has
changed quite dramatically through time. Absent general improvements in health,
we would expect the large number of marginal survivors to reduce indices of
health status at any given age. Of course, the dramatic reductions in mortality
could have been accompanied by progress in lowering morbidity rates as well. We
consider this possibility in Section III. First, we consider some implications
of continuing reductions in mortality.
I.B. Future Trends
Demographic forecasts are notoriously difficult. The substantial mor-
of
tality gains /the last decade were largely unforecasted. Most observers expected
a levelling off in the rate of decline of death rates among the elderly.
Nonetheless, it is useful to consider the potential effects on the future popu-
lation of continued mortality reductions. We rely on the Social Security
Administration's Office of the Actuary, which computes three alternative sce-
narios reflecting different degrees of optimism about future mortality
reductions.^ Alternative II assumes the continuation of current trends, with a
gradual adjustment to moderate rates of mortality progress. Alternatives I and
III respectively consider slower and faster progress in reducing mortality.
Table 3 displays information on projected death rates. If current
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Table 3
Projected Reductions in Mortality, 1980-2080
DEATH RATES PER 1000
Actual Projected Projected Projected
Aqe/Sex Group
-64
1982
20.3
2000 2040 2030
Male 60 15.2 13.3 11.9
Male 55 -59 33.7 28.0 23.8 20.6
Male 70 -74 49.0 41.4 35.2 30.2
Male 75 -79 74.8 53.9 53.9 46.2
Male 80 -84 105.2 90.7 76.2 64.9
Male 85 -89 158.4 135.1 112.5 95.2
Male 90 -94 225.8 191.5 158.5 131.8
Female 60-64 11.2 9.7 8.2 7.0
Female 55-59 15.9 14.8 12.5 10.6
Female 70-74 25.3 20.5 17.1 14.4
Female 75-79 41.1 31.2 25.5 21.1
Female 80-84 55.5 49.0 39.5 32.3
Female 85-89 112.2 84.8 57.5 54.7
Female 90-94 177.5 140.9 111.1 88.9
Source : U.S. Department of Health and Human Services, Social Security
Administration, Office of the Actuary, Actuarial Study No. 92, Social
Security Area Population Projections, 1984 . Projections make
Alternative II mortality progress assumptions.
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trends continue, the death rate at age 75 for women is expected to decline 24
percent by 2000. At this point, it will be fully 45 percent below its 1960
level. By 2080, the death rates for women at all ages over 75 are projected to
be approximately half their current level. For men, progress is less dramatic
but still implies a forty percent mortality reduction at high ages.
Table 4 shows the movements in life expectancy at age 65 which these
projections imply. We report the forecasts under all three mortality scenarios.
Dramatic improvements are clearly a possibility. Under Alternative II, the life
expectancy for men at age 65 will rise by 42 percent, to nearly 20 years, by
2040. For women, even the pessimistic projections suggest life expectancies at
65 in excess of twenty years by 2040. The optimistic scenario suggests values
of more than 25 years by 2040, and over 29 years by 2080.
These reductions in mortality have important implications for the
size and structure of the aged population. In 1982, there were 27.5 million
persons in the 65+ age category; this constituted 11.4 percent of the total
population, and 19.8 percent as many people as the the population aged 20-64.
By 2040, the Alternative II projections imply that the 65+ age group will
include 68.8 million persons, or 21.1 percent of the total population and 39
percent as many as the 20-64 age group. The average age of those over age 65
will also rise. If the optimistic projections are accurate, the share of the
aged population which is over 85 will rise from 9.7 percent in 1985 to 16.2 per-
cent in 2040. The population at older ages will contain many marginal sur-
vivors. Of the 65 year olds alive in 1965, 23.8 percent of the men and 44.6
percent of the women were still alive in 1985. The intermediate projections of
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Table 4
Projected Changes in Life Expectancy
at Age 65, 1980-2080
YEAR
1980 2000 2040 2080
Men
Projection I 14.0 14.8 15.6 15.4
Projection II 14.0 15.7 17.1 18.5
Projection III 14.0 16.6 19.9 23.3
Women
Projection I 18.4 19.5 20.5 21.5
Projection II 18.4 ' 20.7 22.5 24.3
Projection III 18.4 21.8 25.5 29.1
Source : U.S. Department of Health and Human Services, Social Security
Administration, Office of the Actuary, Social Security Area
Population Projections, 1984 .

-16-
the Social Security Actuary suggest that 39.6 percent of those between 65 and 70
in 2000 will be alive in 2020. Less dramatic increases in the proportion of 65
year olds living to be 75 can also be projected.
These data suggest that progress in reducing mortality is having and
will have an important impact on the composition of the aged population. These
effects are potentially important because there are great differences among the
aged in the medical and institutional resources they require. In 1982, the most
recent year for which data are available, medical expenditures per capita for
persons over 85 were about twice as great as those for persons between 55 and
66."^ The rate of institutionalization was 11.3 times as great for men over age
85 as for those between 65 and 74.^ For women, the comparable ratio was 14.6.
These figures suggest that the dependency burden of the elderly population could
increase substantially with time. It also seems reasonable to expect that the
health status of marginal survivors will be worse than that of the remainder of
the population.
The adverse effect of increased survivorship on the health status of
the elderly population may of course be offset by improvements in our ability to
treat chronic illness. The next section presents a formal framework for
thinking about the effects of reduced mortality on the health status of the
population. In the last two sections, we examine the relative importance of
improvements in our ability to manage chronic illness and the changing com-
position of the population in determining the health status of the elderly.
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II. A Formal Model of Mortality Reductions
The interactions between progress in reducing mortality and the health
status of the surviving population are complex. On the one hand, measures which
lower mortality may also improve health status. Reductions in smoking, improve-
ments in diet, and improved control of hypertension probably improve health at
all ages. On the other hand, reductions in mortality may also raise morbidity
by changing the composition of the surviving population. An obvious example is
provided by those whose lives have been extended through the widespread availa-
bility of kidney machines. Mortality reductions also raise morbidity by
increasing the average age of the population.
The relative importance of these two effects has been the subject of
some dispute. Victor Fuchs^ and Richard Fries^"^ take the optimistic view that
health progress is likely to be associated with reduced morbidity. Other
authors, notably Manton^, take the opposite view and suggest that the burden of
caring for the elderly population will rise as mortality falls. Which view is
correct depends on the source of mortality reductions. Kidney machines and
exercise programs will differ in their effects on the health status of the aged
population. Ideally, an analysis of recent trends would focus on the differen-
tial sources of reduced mortality. However, it is notoriously difficult to iso-
late the reasons for declining mortality among the elderly. We therefore
present a general framework which formalizes the effects of lower mortality
rates on health status. 12 This first part of the section presents a theoretical
model of mortality in heterogeneous populations, and the second part applies it
to analyze the gains in mortality during the last forty years.

11
II. A. Population Heterogeneity and Mortality
We present a model due to Vaupel , Manton, and Stallard^^ (VMS) which
permits decomposition of observed changes in death rates into a component due to
health progress which affects all individuals, and a component due to the
changing average frailty of the population. The model is stylized in assuming
that each individual is endowed with a "frailty" at birth which remains constant
throughout life. However, it successfully captures the notion that health
progress which reduces the risk of death for all individuals will raise the
average frailty of the surviving population, especially at very advanced ages.
This composition effect may partly mask mortality improvements.
We assume that the force of mortality for individual i, in cohort j, at age
J
t, )i.(t), is the product of two terms:
M-j(t) = z.V(t) (1)
where li'^lt) equals the cohort-specific force of mortality for persons of age t,
and z. is person i's frailty at birth. ^^ The force of mortality and the age-
specific death rate, q. (t), are linked by the approximation
q.(t) = Pr (person i in cohort j dies between ages t and t+1,
conditional on reaching age t)
= - logd - M^(t)). (2)
The probability that a type-z. individual will survive to age m, S-^(m), is
m . m .
S-j(m) = exp(- / u-J(t)dt ) = exp(- z / ix^{t)dt ). (3)
_j
The population force of mortality at each age, ii (t), is just a weighted
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average of individuals' pi. (t)'s. It depends upon both the distribution of
frailties among those who are alive, and the cohort-specific force of mortality
fjc^(t). From equation (1),
MJ(t) = iJ(t) . M-^'(t) (4)
where z-^(t) equals the mean frailty of survivors in cohort j at age t. The rate
of morbidity, u-^(t), can also be modelled as a function of average frailty and a
cohort-specific morbidity function, i;-'(t):
uJ{t) = *(2J(t)) . vht). (5)
The
<t> function translates mortality-relevant frailties into morbidity-relevant
ones. The cohort-specific morbidity function is designed to capture various
factors such as medical progress which affect morbidity.
To make this model operational, we must make some assumption about the
distribution of frailties at different ages. We define f-^(2,t) as the probability
density function for frailties of individuals in cohort j at age t. Vaupel
,
Manton, and Stallard assume that frailties at birth follow a gamma distribution.
The gamma is sufficiently flexible to allow for a wide variety of distribution
patterns. It also has the appealing property that if frailties at birth are
gamma distributed, then so are frailties of the survivors at all subsequent
ages. We postulate that
f-^(z,0) = X z e ^ /r(k) (6)
which is the gamma density with parameters X. and k. It's mean is k/X., which
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equals one, the average frailty of individuals at birth. This implies k = X..
2 2
The variance equals a.(0) = k/\.. VMS show the density of frailties for age-t
survivors is:
. . -A .(t)z
fJ(z,t) = [Xyt)] z'^'^e ^ /r(k). (7)
The parameters of this gamma distribution are A.(t) = X.- log S-^(t) and k.
S-'{t) is the fraction of cohort j surviving to age t. Using (7), the average
frailty of age-t survivors is therefore
i-^'(t) = k/[Xj - log sJ(t)] (8)
and the variance in frailties at age t is
a^(t) = k/[\. - log sJ(t)]^ (9)
Using the fact that X. = k, the mean frailty at age t may be rewritten as
P{t) = k/[k - log S-^(t)]. (10)
Average frailty declines as a cohort ages, since death is more likely to remove
frailer members of the population at earlier ages. The variance of frailties is
also a declining function of age. This is intuitively reasonable, since at very
advanced ages only the strongest members of the original population, those with
the lowest z's, will remain alive.
The importance of accounting for heterogeneity rises with age. This
can be illustrated by considering a reduction in mortality which lowers the
cohort specific force of mortality by a constant fraction (6) at all ages:
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|i(t) = 6./j(t) (11)
This mortality improvement will affect the mean frailty of the very old by more
than that for other groups, although the measured death rates for this group
will be the least influenced by this improvement. This is because the change in
mortality at each age has two components:
dMlii
__
d(a,(t)i(t)) ^
-(,)^(,) , ^(^^diiti a . (12)
The first term yields a reduction in mortality rates as 5 falls. It corresponds
to the direct reduction in the mortality rate for persons who survive to each
age. The second term has the opposite effect; as 6 falls, it shows that average
frailty at each age will rise, causing some increase in the observed age-
specific death rate. At all ages average frailty rises as 5 falls, i.e.,
dz(t)/d6 is less than zero, signalling a mortality improvement. This effect
is largest at old ages. Since the direct reduction in mortality rates is a
constant proportion at all ages, the observed response to an improvement such as
(11) will be smallest at high ages. This is what one would expect intuitively.
The selection effect of mortality improvements cumulates through time, and so
has its greatest impact at high ages.
A central insight which follows from models of mortality in heteroge-
neous populations is that the mortality prospects facing an individual may be
poorly described by observed population death rates. Because selection operates
to increase the fraction of stronger individuals in the population as it ages,
the life expectancy which one would estimate from the actual survival curve will
always overstate the life expectancy for an average individual at birth. The
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relationship between the force of mortality for a type-z . person at age t, and
the observed cohort force of mortality at that age, is
|jJ(z.,t) = MJ(t)*z.*(sJ(t))"^/'^ (13)
where S (t) is the fraction of cohort j which has survived to age t.l^ This shows
that the divergence between the risks facing an individual of any given frailty,
and those observed to face the population, rises with age since S-'(t) declines.
It follows that observed progress in reducing mortality will tend to understate
true progress in reducing mortality at old ages. This is because the aged popu-
lation following a reduction in mortality contains marginal survivors whose
experience is likely to be less favorable than that of other members of the
population.
Models of population heterogeneity similar to the one described above
have often been proposed as potential explanations of the "crossover effect,"
the observation for example that mortality rates for very old black women in the
United States are lower than those for whites, although at earlier ages the pat-
tern is just the opposite. Crossovers are possible when populations are
comprised of heterogeneous individuals, since high mortality rates in early life
may select a very hardy pool of survivors. A growing body of evidence, however,
suggests that observed crossovers may be spurious artifacts of poor demographic
data and inaccurate age reporting. Coale and Kiskerl^ demonstrate a strong
correlation between the frequency of "age heaping," the tendency for ages which
end in five or zero to attract a higher fraction of census responses than the
adjoining ages, and the presence of cross-over effects in a sample of
demographic data for 20 countries. Even if heterogeneity is not the full expla-
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nation for crossovers, however, models such as the one described here could
capture an important aspect of health progress. ^'^
The model which we have sketched imposes several strong restrictions
on the nature of mortality reductions. For example, a reduction in the
cohort's baseline mortality, ji-^(t), affects very frail individuals much more
than those who were initially healthy. There are undoubtedly some forms of
medical progress which affect healthier individuals more than those who are
extremely frail, and it would be desirable to allow for such progress in a more
general framework. There also may be errors introduced by our assumptions about
the functional form of the frailty distribution, although it is difficult to
assess their impact. Finally, when we make comparisons across cohorts born at
different ages, we assume that the average frailty at birth is the same for each
cohort. This seems a natural starting point, although further work might exa-
mine the extent to which changing patterns of neonatal care could influence the
value of z-^(O) across cohorts.
II.B. Application to Recent Mortality Gains
When we normalize the mean cohort frailty to unity at birth, paramet-
erizing the frailty distribution then reduces to the problem of choosing k.
The variance of frailties at birth is equal to 1/k. As k rises, the dispersion
of frailties declines until in the limiting case of k=<xi, there are no differen-
ces among cohort members.
Manton, Stallard, and Vaupel^^ analyze mortality data on the cohorts of
white men and white women born in the United States in five year intervals bet-
ween 1850 and 1880. They estimate that k equals 3.93 for the male population,
and 2.84 for women. They obtain similar results using Swedish data. We
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attempted our own estimates of the variance in frailty among the aged popula-
tion by trying to fit the observed cohort life tables, assuming a mixture of
individual Gompertz mortality functions. These efforts failed to yield reaso-
nable estimates. The results suggested a complete absence of heterogeneity.
This may have resulted from our assumption about the functional form of the
individual hazard functions. It would be valuable to reconsider the estima-
tion in future research.
Our analysis assumes k=4.0 for both men and women; this probably
overstates k and understates the dispersion of frailty. The parameters imply
that 81.5 percent of men at birth have frailties between one-half and twice the
average frailty. To illustrate the difference between the population mortality
experience and that facing an individual of constant frailty, we compute the
probabilities of dying each year for a man who was born in 1880 with a frailty
of 0.56, the average frailty for those who survived to age 55. We then compare
the probabilities that he will die in each year after age 55 with the observed
cohort death rates for these ages. The two sets of death rates, denoted
q (t) and q-^{.56,t) are plotted on Figure 1. As time elapses after age 55, the
difference between the constant frailty individual's probability of dying and
that for the cohort as a whole widens. At age 60, for example, the observed
death rate is 0.237, while that for our constant-z individual is 0.245. By age
75, the difference is more dramatic: 0.645 versus 0.778. These trends reflect
the declining average frailty of the surviving population; our constant-frailty
person is increasingly among the frailest members of the surviving cohort. At
age 60, he is frailer than 58.3 percent of the suriving cohort; by age 75, 68.3
percent are less frail.
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We use the Vaupel-Manton-Stallard technique to analyze changes in mor-
tality rates and life expectancy for individuals born in 1880 and 1910. First,
we calculate the observed change in mortality rates and compare it with the
change which would have taken place assuming that the average frailty of sur-
vivors in the 1880 cohort had applied to similar-aged survivors in the 1910
cohort. We also compute the changes in life expectancy at each age between the
two cohorts, again making corrections for movements in average frailty. This
enables us to identify the ages at which substantial mortality gains have taken
place.
Computing life expectancies requires data on the probability of death
at ages up to 100 because the exact age at which people die is important.
Unfortunately, the maximum age reported in our cohort life tables is 85. For
the 1910 cohort, data are available on persons up to 72 years of age. We
extended our tables to age 100 by fitting a Gompertz curve, a standard func-
tional form relating age and the force of mortal ity,l^ to our data on each
cohort's death rates at ages between 55 and 85. We then use this curve to pre-
dict values of death rates at ages greater than 85. The Gompertz curve
specifies that the force of mortality rises exponentially over time:
)j-^(t) = |i-^(a)e'^^ ~^' where a in our estimates equals 55. This specification
implies simple regression models for mortality rates:
log(-log[l-qJ(t)]) = a^ + pj*(t-50) + e^^ . (15)
The results of our estimates for each cohort are shown in the appendix.
The probabilities of death which would have been observed for the 1910
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cohort had average frailty at each age equalled that for the 1880 are:
~1910(-1880(^)^^^ = 1 - exp[-k*log(l-?^l°(t))*il««°(t)/il91°(t)]. (14)
The expression depends upon z (t), the average frailty at age t for the
— 1 880
survivors in the 1910 cohort, and z (t), the average frailty for survivors
from the 1880 cohort when they were t years old. The results of these calcula-
tions are shown in Table 5, which reports the actual q and q and the
frailty-adjusted death probabilities at five year intervals for both men and
women. The table shows that for men, the probability of dying at age 55
declined from 0.0341 to 0.0291 between the 1880 and 1910 cohort, a decline of
0.0050. At age 80, the decline was more pronounced, from 0.0954 to 0.0578. The
table also shows that the decline would have been even larger at both ages if
the average frailty of the respective populations had remained constant at their
1880 level. The change at age 65 would have been 0.0067, while at age 80, the
constant-frailty decline in death rates equals .0430. Figure 2 shows the reduc-
tions in death rates, with and without our frailty adjustment, for all ages bet-
ween 55 and 85. The figure vividly demonstrates that the largest reductions in
mortality occured at very advanced ages. While a male survivor's probability of
dy.ing falls by nearly one quarter at age 55, it is reduced by roughly fifty per-
cent at all ages above 80.
The table shows that even more pronounced changes have occurred for
women. At age 65, the observed mortality rates declined from .0229 to .0135
between 1945 and 1975, the dates when women in the 1880 and 1910 cohorts turned
65. Adjusting for changes in frailty yields a relatively small additional
improvement, converting the 1975 mortality rate to .0125. At older ages, the
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Table 5
Changes in Actual and Frailty-Adjusted Mortality Rates, 1880-1910 Birth Cohorts
Actual Probabilities of Death, Men
Aqe
-1880
a:
1880 -1890
-q
-1890 -1900
q -q
-1900 -1910
q - q
-1910
55 1.65 0.09 0.21 -0.01 1.35
60 2.37 C.16 0.14 -0.03 2.10
65 3.41 0.25 0.02 0.23 2.91
70 4.66 0.13 -0.11 0.84 3.80
75 6.45 -0.11 0.12 1.54* 4.90*
•80 9.54 0.04 0.51 3.11* 5.78*
85 14.51 1.80 2.00* 4.15* 5.56*
Probabilit ies of Death Assuminq 1830 Frai Itv Levels, Men
Aqe
-1S80
q
1.55
i1880 -1890-q -1890 -1900q -q
0.25
-1900 -1910
q - q
0.02
-1910
q
55 0.11 1.23
60 2.37 0.19 0.20 C.Cl 1.98
65 3.41 0.30 0.11 0.27 2.73
70 4.55 0.20 0.02 0.39 3.55
75 5.45 -0.02 0.29 1.54* 4.54*
80 9.54 0.17 0.85 3.28* 5.24*
85 14.51 2.02 2.40 * 4.43* 5.76*
Actual Probabil-it ies of Death, Women
Aqe
-1880 i1S30_-139C -1890 -1900q -q -1900 -1910q - q -1310q
55 1.17 0.23 0.25 0.04 0.55
60 1.57 0.35 0.23 0.04 0.35
65 2.29 0.54 0.23 0.17 1.35
70 3.07 0.45 0.25 0.51 1.85
75 4.50 0.43 0.44 0.93* 2.55*
80 7.21 0.94 0.94 2.19* 3.14*
85 11.93 2.45 2.94* 2.95* 3.63*
Probabilit ies of Death Assuminq 1330 Frai Itv Levels, Women
Aqe
-1830
q i1880 -1890-q -1890
-1900
q -q
-1900_ ^1910 -1910
q
55 1.17 0.25 0.27 0.05 0.61
60 1.57 0.37 0.25 0.06 0.88
55 2.29 0.58 0.28 0.19 1.25
70 3.07 0.52 0.33 0.52 1.70
75 4.50 0,51 0.55 0.94* 2.33*
80 7.21 1.17 1.14 2.15* 2.76*
85 11.98 2.90 3.18* 2.88* 3.02*
Source: Authors calcu lat ions based on unpublished ccihort life table data for
while men and while women provided by the Metropolitan Life Insurance
Company. The q series are actual cohort death rates, while ^ are the death
rates which would have been observed if the average frailty of the 1880
cohort had prevailed at all times. Starred values are based on extrapolated
death probabilities. See text for details of calculations.
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frailty adjustment matters somewhat more. At age 85, for example, observed
death probabilities fell from .1198 to .0353, while keeping the 1880 cohort's
frailty level, q would have fallen to .0302.
Studying changes in death rates is one way to identify the ages at which
the most progress has been made against mortality. However, the claim that
substantial gains have occured at extreme ages may be of little significance if
the fraction of the population which lives to these ages is trivial. An alter-
native measure of where gains have been made is the change in life expectancy at
a given age between two cohorts.
Our life expectancy calculations are shown in Table 6. The table
shows the actual life expectancies at ages 55 through 85 for individuals born in
1880, 1890, 1900, and 1910. The changes in life expectancy for both men and
women occur disproportionately between the last two cohorts. For example, a
man born in 1880 who lives to age 75 has a life expectancy of 8.3 years. If he
had been born in 1900 and reached age 75, his life expectancy would be 9.3
years. However, an individual born just ten years later, in 1910, has a life
expectancy of 12.45 years at age 75. The absolute gain in life expectancy is a
smoothly declining function of age, while the percentage gain rises with age.
The difference between actual and frailty-adjusted life expectancies
can be seen by comparing the first and second panels of the table. If the
average frailty of the 1910 cohort at each age had equalled the same-age average
frailty of the 1880 cohort, life expectancy would have been roughly one year
greater. At age 55, for example, it would have raised male life expectancy from
22.4 to 23.5 years. At age 80, changes from 10.66 to 11.50 years from men, and
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Table 6
Changes in Actual and Frailty-Adjusted Life Expectancies, 1380-1910 Birth Cohort;
Age
55
60
65
70
75
80
85
-1880
e
19.05
15.8.7
13.03
10.56
8.31
6.52
5.44
Actual Life Expectancies, Men
-1890 -1880
e -e
-1900 -1890
e -e
-1910 -1900
e -e
-1910
6
0.46 0.59 2.29 22.41
0.36 0.51 2.55 19.29
0.25 0.50 2.87 16.65
0.25 0.53 2.98 14.32
0.33 0.70 3.10* 12.45*
0.45 0.84 2.84* 10.66*
0.57 0.51*
.
2.21* 8.83*
Age
55
60
65
70
75
80
85
Age
55
60
55
70
75
80
85
Life Expectancies Assuming 1880 Frailty Levels, Men
L8o0
19.05
15.87
13.03
10.55
8.31
5.52
5.44
-1880
e
22.55
19.01
15.75
12.75
10.04
7.78
5.37
-1890 -1380
e -e
-1900 -1890
e -e
-1910 -1900
e -e
-1910
0.61 0.93 2.85 23.45
0.50 0.82 3.12 20.31
0.38 0.80 3.44 17.55
0.37 0.81 3.57 15.31
0.45 0.96 3.71* 13.42*
0.57 1.10 3.42* 11.50*
0.70 0.84* 2.58* 9.55*
Actual L ife Expectancies, Womei
-1910 -1900
e -e
-1890 -18
e -e
30 -1900 -1890
e -e
2.14
-1910
1.94 3.48 30.12
1.71 1.97 3.50 25.28
1.43 1.85 3.72 22.75
1.27 1.74 3.58 19.45
1.16 1.77 3.58* 15.65*
1.15 1.77 3.21* 13.92*
1.01 1.43* 2.30* 11.11*
Life Expectancies Assuming 1880 Frailty Levels, Women
Age
55
60
55
70
75
80
85
Source:
-1880
e
22.55
19.01
15.75
12.76
10.04
7.78
5.37
-1890 -1380
e -e
-1900 -1890
e -e
-1910 -1900
e -e
-1910
e
2.30 2.56 3.39 31.40
2.06 2.46 4.00 27.54
1.78 2.34 4.10 23.95
1.61 2.21 4.03 20.61
1.49 2.21 3.98* 17.72*
1.45 2.18 3.45* 14.87*
1.30 1.75* 2.43* 11.36*
Authors calculations based on unpublished cohort life table data
white men and white women provided by the Metropolitan Life Insurance
Company. The e- series are the actual life expectancies for each cohort,
while the § are those which would have prevailed if average frailty at each
age had remained constant at the 1880 cohort levels. Starred values are
based on death rate extrapolations. See text for details of calculations.
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13.92 to 14.87 years for women, would be observed. Put another way, the margi-
nal survivors at each age have lower life expectancies than those who would have
lived to that age in the previous cohort. Since the difference between the
actual and frailty-corrected estimates is approximately the same at all ages,
the proportionate change induced by the frailty correction is largest at old
ages.
These data cast doubt on the view of Fries and Crapo^O and others that
longevity is currently pushing up against an upper limit. Taking account of
heterogeneity, it appears that life expectancy is increasing more at old than
young ages. It is increasing more for women than for men, even though women
already have longer life expectancies. We find little evidence to confirm the
view that mortality is increasingly bunched at some specific age. Apparent evi-
dence of life curve rectangularization could be a manifestation of heteroge-
neity.
The results in this section suggest that if the framework sketched
here is roughly accurate, the changing frailty mix between the 1880 and 1910
cohort should have reduced the gains in both mortality rates and life expectan-
cies which would have taken place under if the survivors were of the same
frailty as those in the 1880 cohort. These substantial changes in average
frailty should also have had other effects. If a larger fraction of the popula-
tion survives until age 65, then the variance of frailties at that age will
increase. This should imply an increase in the variance of longevities after
age 65. For men reaching age 65 in 1925, the variance of the remaining years of
life was 40.7; for those reaching 65 in 1965, it was 66.5. The comparable
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figures for women in these two years were 45.2 and 87.0, respectively. This
accords with the predictions of the heterogeneity model.
A second prediction of this model is that falling mortality rates
should have lowered the average health status of the population at advanced
ages. Health status is difficult to describe using a single quantitative
measure. In the next section we see if any dramatic changes are suggested by
several kinds of evidence of health status.
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III. Evidence on Changing Morbidity and Health Needs
While it is difficult to assess the extent of heterogeneity in the
population, the analysis in the preceding section suggests that changes in mor-
tality rates could result in important changes in the composition of the sur-
viving population. If this were the only force acting on the health status of
the aged, one would expect to see substantial deterioration, especially among
those at high ages. This supports the pessimistic view of health progress.
Another explanation could also be proposed to account for reductions in health
status. Episodes of morbidity may weaken individuals. Recent progress may have
raised the threshold below which an individual's resilience may fall without
causing death. If illness-induced reductions in resilience are persistent, then
health progress may raise the average frailty (lower resilience) of the sur-
viving population.
Victor Fuchs' recent optimistic analysis of changes in health status^l
does not consider the changing composition of the aged population. Rather, he
focuses on the effects of broadly-defined health progress on the health status
of a given aged person. He proposes an intruiging model for thinking about the
linkages between aging and health. He argues that for medical care costs, disa-
bility, and institutionalization, age is better measured backwards from death
rather than forwards from birth. Medical care costs, for example, have been
shown to be highly concentrated in the year or two immediately preceding death.
Since death rates at all ages have declined, Fuchs' view would lead to the
expectation that the health status of the elderly population should actually be
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improving since the average number of years till death is rising. The fraction
of the population at each age who are within one or two years of death has
declined, as evidenced by changing death rates. Fuchs' view predicts that one
should see greater improvements in health status at old ages than at younger
ages because of the greater absolute reduction in death rates among the elderly.
Any other view emphasizing the importance of medical developments or changes in
lifestyle in reducing morbidity would also lead one to expect trend improvements
in the health of the elderly.
These two views thus offer dramatically opposite predictions about trends
in the health status of the elderly population and about the relative health
status of persons at different ages. One cannot doubt the existence of both
positive developments which reduce morbidity, and changes in the composition of
the population which tend to increase illness and disability. The central
question is which effects predominate. To investigate this issue, we examine a
number of indices of the health status of the elderly. When possible, we look
at age-specific measures to avoid biases due to the aging of the population.
Table 7 reports the fraction of the aged population residing in nursing
homes for various years between 1963 and 1982. Annual data on the nursing home
population are not collected; we report the findings of the five most recent
surveys. For both men and women under 85, the data show a steady upwards trend
in the rate of institutionalization from 1963 until 1977 and then a small
decline in 1982. There is a substantial increase in institutionalization rates
at all ages between 1963 and 1969. At least the first part of this increase
may reflect increases in the level of public support for nursing home care.
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Table 7
0.99 1.13 1.27 1.23
3.50 4.08 4.74 4.17
,3.08 13.04 14.00 13.93
Women
65-74
75-84
85+
Percentage of Population Resident in
Nursing Homes-. 1963 - 1977
Year
Age/Sex Group 1963 1969 1973 1977 1982
Men
65-74 0.68
75-84 2.91
85-f 10.56
Source : Data for 1963-1977 are drawn from U.S. Department of Health and Human
Services, Public Health Service, Vital and Health Statistics , Series 13
Number 51-. Characteristics of Nursing Home Residents: Health Status,
and Care Received
, 1981, p. 4. The 1982 calculations are based on
unpublished data from the National Master Facility Survey provided by
the National Center for Health Statistics.
0.88 1.29 1.31 1.59 1.55
4.75 5.23 7.11 3.05 6.39
17.51 24.75 29.05 25.15 22.59
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especially through Medicaid. 22 jhe pattern among very old men and women, those
over 85, is quite different, however. The rate of institutionalization rises
steadily until 1973 and then declines sharply through 1982. This pattern is
rather surprising. Non-health determinants of the rate of institutionalization,
such as the availability of public assistance or increased viability of
remaining at home, would be expected to exhibit similar trends for all age
groups. Thus, these data might suggest that the health status of the very old
is improving relative to that of their younger counterparts.
An interesting feature of the data is that at all ages women have con-
siderably higher rates of institutionalization than do men despite their longer
life expectancy. This probably reflects their much greater likelihood of being
widowed. The data also reject popular stereotypes about the pervasiveness of
institutionalization. Even for the extreme aged, less than one-fifth of the
population is in a nursing home. Only about five percent of the elderly popula-
tion is institutionalized at any point in time. 23 Unfortunately, it is dif-
ficult to draw stong conclusions about the health status of the elderly from
institutionalization rates, since much of the variation in this rate may be due
to non-health factors.
Information on the pattern of Medicare expenditures on persons of dif-
ferent ages is presented in Table 8. Because the overall level of Medicare
spending is driven by economic and non-economic forces beyond the scope of this
paper, we focus only on relative levels of expenditure on persons of different
ages. The table reports the average Medicare reimbursement per enrol lee in each
age group, scaled by the average reimbursement per enrol lee in the 65-66 age
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Table 8
Age-Specific Medicare Expenditure Patterns
Age/Sex Group 1966 1971 1977 19S2
White Men
55-55 1.000 1.000 1.000 1.000
67-58 1.105 1.352 1.049 1.103
59-70 1.152 1.428 1.131 1.189
Wh^ite Womei
55--55
57--58
59--70
71--72
73--74
75-
80-
-79
-8/1
Year
.
1.518 1.215
1.593 1.338
1.763 1.477
2.009 1.540
2.085 1.855
71-72 1.275 1.302
73-74 1.404 1.447
75-79 1.572 1.615
80-84 1.742 1.845
85+ 1.972 6 1.358
1.000 1.000 1.000 1.000
1.199 1.342 1.029 1.098
1.180 1.432 1.100 1.212
1.301 1.567 1.175 1.292
1.398 1.725 1.324 1.412
1.584 1.912 1.522 1.540
1.804 2.207 1.774 1.927
2.019 2.243 1.374 2.036
Notes : Each column shows the ratio of Average Medicare Expenditures per
Enrollee to expenditure per enrollee in the 55-56 age category. Data
are based on authors' calculations, using information drawn from annual
issues of Medicare Program Statistics , and Health Care Financing:
Program StBti sties published by the Health Care Financing
Administration.
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group. The data show very little variation over time in the age pattern of
Medicare expenditures. The ratio of expenditures on enrollees over 85 to those
between 65 and 66 was 1.97 for white men in 1966, and 2.02 for white women. In
1982, the comparable values were 1.96 and 2.10, respectively. Similar patterns
emerge in other years and at intervening ages, with one exception. To some
extent, 1971 is an outlying year. This appears to be entirely due to unusually
low expenditures on persons aged 65 to 66. Relative levels of expenditures bet-
ween other ages are not out of line with the data for other years. Movements in
the fraction of enrollees who receive some medical services also show a similar
pattern. In 1966, 30.2 percent of Medicare enrollees between 65 and 66 years of
age received service, compared with 48.2 percent of those over age 85. In 1982,
the rates were 57.5 percent and 73.3 percent, respectively. The growth in uti-
lization was larger for those at younger ages than for the very old.^^
Data on both utilization and care levels suggest that the effects of
health progress and the changing composition of the population have offset each
other. They do not support the view that health progress inevitably carries
with it huge expenditure burdens for marginal survivors, as the heterogeneity
model of the last section would suggest. While close to half of the 1982 popu-
lation of persons over 85 were marginal survivors, compared to a lower fraction
in earlier years, relative Medicare costs remained roughly constant.
Data on Medicare expenditures and institutionalization have the virtue
of being objective, but the problem of being influenced by a variety of factors
other than the health status of the elderly. Another source of health status
information is the extent of activity limitation and disability in the elderly
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population. Data on these health measures for the civilian noninstitutional
population are collected in the Health Interview Survey, and tabulations are
periodically published by the National Center for Health Statistics. Table 9
presents information on the number of restricted activity days per year for
subgroups of the elderly population for various years. Because the numbers
refer only to the non-institutionalized population, they may be heavily
influenced by fluctuations in the institutionalization rate, especially since
persons in institutions are likely to have substantial amounts of restricted
activity. 25
In general, the data on restricted activity display no clear trend.
The reduced morbidity and frailty-composition effects of medical progress again
seem to offset each other. The incidence of restricted activity days for both
men and women aged 75-plus is nearly the same in 1980 as in 1961. For the 65-74
age group, there is slight evidence of an increase in disability days when we
focus on the 1980 data. This trend is not present in the 1975 survey, however.
These data confirm the inference drawn from the data on institutionalization;
the health of the elderly has not worsened and may have improved in recent
years. In particular, they offer no support for substantial reductions in
health at extreme ages where the incidence of marginal survivors is greatest.
Similar conclusions are suggested by information on the incidence of
Bed Disability Days in Table 10, which also appear to be relatively constant
between 1961 and 1980. For all age groups except women aged 54-74, the inci-
dence of bed disability days was lower in 1980 than in 1961. In some cases,
such as women aged 75-plus, the improvement suggests an average reduction of
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Table 9
Average Number of Restricted Activity Days per Person,
Year
1961
1953
1965
1958
1971
1975
1980
Source : U.S. Public Health Service, Vital and Health Statistics , Series 10,
various issues entitled Disability Days .
Men 55-74 Men 75+ Women 65-74 Women 75+
31.9 35.1 34.8 46.2
31.3 41.4 35.3 49.5
30.9 35.0 30.7 41.9
31.2 35.0 30.3 47.6
25.6 38.
8
30.5 44.9
31.1 40.7 35.2 49.2
34.2 35.0 39.2 45.5
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Table 10
Incidence of Bed Disability Days Among Person Over Age 65
AGE/SEX GRO'JP
Year Men 65-74 Men 75+ Women 55-74 Women 75+
1961 11.4 14.5 12.5 23.6
1963 10.8 17.5 11.3 20.0
1965 11.5 14.5 11.1 16.0
1968 12.0 16.2 11.6 20.9
1971 9.0 17.9 10.9 18.9
1975 9.8 17.0 10.5 17.7
1980 10.9 13.4 12.9 19.1
Source : U.S. Public Health Service, Vital and Health Statistics , Series 10,
period volumes entitled Disability Days .
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nearly one week per year of disability. For men over 75, a substantial improve-
ment in health status is observed between 1975 and 1980, parallelling the obser-
vations made above. The principal gains for extremely old women occurred during
the 1960s. An interesting aspect of the data is that the disability rate is
higher for women than for men, particularly in the over-75 category. This tends
to contradict Fuchs' view that time until death is a good indicator of health
status, since women have longer life expectancies than men. It is consistent
with the heterogeneity view since a much larger fraction of women than men reach
the age of 75.
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IV. Microeconometric Evidence
The data presented in the preceding section suggest that the health
of the elderly population has not changed much through time despite the changing
composition of the elderly population and progress in reducing morbidity. This
suggests that these two effects have been roughly offsetting. In this section
we present some very crude microeconometric evidence bearing on this question.
We test Fuchs' hypothesis that "relevant age" should be measured backwards from
death rather than forwards from birth by making use of longitudinal data from
the Retirement History Survey. The survey includes information on individuals'
ages as well as dates of death for the quarter of the original sample which died
between 1969 and 1979. We compare the power of the age and time-til 1 -death
variables in explaining hospital care costs. Because hospitalization costs are
only one indicator of health status, we also compare the performance of the two
age variables as predictors of retirement decisions.
The Retirement History Survey suffers from several drawbacks as a
source for an investigation of this type. First, it only provides data on the
youngest part of the aged population. Even at the end of the sample, the oldest
person in the sample was only 73. Second, the information on medical costs in
many years refers only to out of pocket expenses. Since individuals become eli-
gible for Medicare at age 65, it is not possible to satisfactorily estimate the
effects of chronological aging on health care costs except for those under 55.
The existence of other third-party payments also makes these data difficult to
interpret. In 1969, however, before any survey participants were eligible for
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Medicare, the survey asked for detailed data about hospital costs borne by both
the respondent and any third parties. We use only this information in our study
of health care expenditures.
We estimate hospital cost equations of the form:
HCOSTi = ao + ai*MAR-i + a2*EDUC-i + a3*SMSA-i + a4*RACE^-
+ a5*AGEi + a6*YTDi + a7*SURVIV0Ri + e-j .
where MAR is a dummy variable equal to one for persons who were married, EDUC
represents years of schooling, SMSA is a dummy variable equal to 1 for persons
residing within an SMSA, RACE equals 1 for non-whites, AGE is chronological age,
and YTD equals years to death. The survey records both month and year of death,
so we are able to measure this variable quite accurately. We also include
SURVIVOR, a dummy variable equal to one if the respondent survived until the end
of the sample period. We assigned these individuals the maximum value for YTD
as well. The dependent variable is total hospital costs during 1968. No econo-
mic variables like wealth were included in the equation because of the possibi-
lity that they were affected by individual choices based on knowledge of health
status.
The results of several specifications of the hospital cost equation
are shown in Table 11.^6 increases in age, and reductions in the number of years
to death, both raise hospital costs. A one year reduction in years to death has
a slightly larger effect on costs than one additional calendar year of age. The
most important finding, however, is that the effects of age and time-till-death
are largely independent. Although equations including the time-till-death
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Table 11
Reduced Form Hospital Cost Equations, 1969 LRHS Sample
Constant
MARRIED
EDUCATION
SMSA
RACE
AGE
YEARS TO
DEATH
SURVIVOR
Equation 1
1183.7
(604.6)
70.9
(54.3)
4.3
(8.1)
57.7
(34.1)
-35.4
(74.3)
19.7
(10.3)
Equation 2
193,,7
(95,•7)
78,.7
(54,.1)
7,.3
(8,.1)
70,,5
(34,.1)
-21
,
.4
(74,.1)
-23.5
(12.1)
-7.7
(58.3)
Equation
-874.0
(609.7)
74.9
(54.1)
5.4
(3.1)
69.4
(34.1)
-25.1
(74.1)
17.8
(10.1)
-24.5
(12.1)
4.3
(58.5)
SSR
r2
177.7
.012
176.1
.021
175.4
.025
Notes: All equations are estimated with 785 observations from the Brookings
LRHS Extract File. Standard errors are shown in parentheses.
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variable fit significantly better than those with only age in the specification,
controlling for time-til 1-death does not appreciably affect the coefficient on
the age variable. This suggests that the relationship between medical costs and
age is not a spurious one, due solely to an underlying relationship between
health care needs and time until death. It does offer some support, however,
for the view that past reductions in mortality rates have led to reduced demand
for health care.
We extended our analysis of health status to also consider the effect
of the two age measures on retirement decisions. Because the 1969 survey inclu-
des a relatively small fraction of retired persons, we report results for both
it and the subsequent 1973 survey. The equation we estimate corresponds exactly
to that for hospital costs above, except that we replace HCOST with a variable
which equals 1 if the person has retired and zero otherwise. The results of
estimating the retirement equation are shown in Table 12. As one would expect,
both AGE and YTD have significant effects on the probability of retirement. The
1973 estimates imply that an extra year of age increases the probability of
retirement by 8.5 percent. Being a year closer to death increases the probabi-
lity of retirement by 7.2 percent. While these effects appear to be comparable,
the important result is again that they are independent. Controlling for time
until death does not change the effect of AGE on retirement for either the 1969
or 1973 samples, again suggesting that there is a genuine link between age and
retirement. This conclusion is buttressed by the time series evidence.
Increases in retirement have occurred rapidly over the past three decades
despite major improvements in life expectancy.
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Table 12
Reduced Form Retirement Equations, 1959 &. 1973 LRHS Samples
1969 Sample 1973 Sample
Equation 1 Equation 2 Equation 3 Equation 1 Equation 2 Equation 3
Constant -0.724 0.534 -0.353 -4.756 0.919 -4.486
(0.379) (0.059) (0.375) (0.728) (0.130) (0.740)
MARRIED -0.163 -0.155 -0.158 -0.027 -0.011 -0,017
(0.034) (0.033) (0.033) (0.051) (0.064) (0.061)
EDUC -0.017 -0.014 -0.015 -0.030 -0.026 -0.029
(0.005) (0.005) (0.005) (0.003) (0.003) (0.009)
SMSA -0.006 0.008 0.007 0.009 0.020 0.015
(0.021) (0.021) (0.021) (0.038) (0.040) (0.038)
RACE 0.107 0.122 0.119 -0.012 -0.C05 __r\ r»'^o
(0.047) (0.045) (0.045) (0.079) (0.083) (0.079)
AGE 0.017 0.015 0.034 0.084
(0.006) (0.005) (0.011) (0.011)
YEARS TO -0.024 -0.026 -0.072 -0.072
DEATH (0.007) (0.007) (0.035) (0.036)
SURVIVOR -o.ois -0.008 0.039 0.154
(0.042) (0.042) (0.100) (0.095)
SSR 68.9 57.4 55.9 139.7 150.5 138.3
r2 .059 .093 .093 .096 .025 .106
No. of Obs. 785 786 785 618 518 618
Notes: Standard errors are shown in parentheses. See text for further descrip-
tion.
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In results which are not reported here, we found that the YTD variable
in both the retirement and hospital cost equations had a highly nonlinear
effect. Imminent death has a strong positive effect on the probability of
retirement, and is very highly correlated with hospital expenses. Further
research could usefully explore these effects in greater detail.
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V. Conclusions
Our analysis of several types of data suggests that neither an extre-
mely optimistic nor an extremely pessimistic view of the impact of declining
old-age mortality is appropriate. Increased survivorship among relatively
unhealthy members of the population has in the past been offset by general
reductions in morbidity, leaving the age-specific health status of the popula-
tion largely unchanged. While projections are difficult, there is no obvious
reason to expect this pattern to change.
This suggests that as a reasonable first approximation, future Medicare
costs or the costs of institutionalization can be estimated using current age
specific information. Projections of this type are somewhat ominous. Based on
1982 age specific rates of institutionalization, and intermediate mortality
assumptions, one can forecast a 53 percent increase in the population of insti-
tutionalized men, and a 67 percent increase for women by the year 2000. By
2020, the increase will be nearly 120 percent. Under the optimistic mortality
assumptions, the corresponding figures are 64 percent for men by 2000, and 79
percent by women. By 2020, both populations have risen to more than 150 percent
of their 1982 level. Based on the most recent profile of Medicare costs by age,
one can forecast an increase of 37 percent by the year 2000 under the inter-
mediate mortality assumptions. The increase would be 43 percent under opti-
mistic assumptions. Since the intermediate mortality assumption implies that
the 65 and over population will increase by 32 percent by the year 2000, these
findings suggest that 22 percent of the increase in male institutionalization.
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and 35 percent of the female increase, will result from aging of the elderly
population. For Medicare, the comparable figures are four and seven percent.
These increases in costs seem large relative to the savings attainable
through improvements in the delivery of health care, or the savings that might
be possible through making consumers bear a larger fraction of health care
costs. This suggests that we must inevitably plan on increases in the share of
national income devoted to taking care of the dependent elderly, even if
substantial improvements in the delivery of care are achieved.
Proposals to redefine the elderly are frequently advanced. The propo-
nents suggest that the age of 65, originally set by Bismark, is no longer an
appropriate demarcation point for defining the elderly. More importantly, it is
often argued that with increases in life expectancy, the normal age of retire-
ment should be increased so as to preserve the ratio of working years to retire-
ment years for the average member of the population. Indeed this principle was
enshrined in the 1982 Social Security reform package which calls for future
increases in the Social Security retirement age. Our analysis suggests that
these policy prescriptions are inappropriate. The data do not support Fuchs'
view that age should be measured backwards from death. Reductions in mortality
do not seem to be associated with reductions in morbidity at each age. There is
little reason to think that the health status of the typical SS-year-old twenty
years from now will be better than it is now. Hence, there is little basis for
proposing a redefinition of the elderly.
Reductions in mortality however will be associated with increases in
the variance of health status at any given age. Medical progress will make the
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best off members of any given cohort still better off, while marginal sur-
vivors are likely to be in very poor health. This suggests the desirability of
flexible policies when dealing with the aged population. Policies based on
necessarily arbitatry age thresholds will become less and less satisfactory as
the dispersion of health status in the population increases.
Our analysis has focused on the effects of mortality reduction taken as
a whole, without distinguishing the cause of mortality reductions. Further
detailed investigations would be extremely valuable, since different types of
reductions in mortality will have different effects. Reductions in accidents,
for example, may not change the composition of the population in an unfavorable
way, while the implantation of artificial hearts will increase dependency among
the surviving population. At the margin, it would probably be desirable to tilt
medical progress towards policies of the first type. The criterion of maxi-
mizing total years of lifespan extension tends to favor policies directed at
persons who, if saved, will be in good health. Maximizing the number of lives
saved in the current year, another criterion, is more likely to lead to saving
individuals who will be unhealthy and have a high risk of death.
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Table A-1
Estimates of Gompertz Models for Mortality Rates, Age 55+
Cohon r2
1880/Male -4.103 0.073 .997
(0.013) (0.0007)
1880/Female -4.531 0.077 .992
(0.023) (0.0013)
1890/Male -4.159 0.075 .999
(0.009) (0.0005)
1890/Female -4.786 0.081 .996
(0.016) (0.0009)
1900/Male -4.247 0.077 .997
(0.013) (0.0009)
1900/Female -5.017 0.085 .999
(0.006) (0.0004)
1910/Male -4.215 0.067 • .986
(0.019) (0.0022)
1910/Feniale -5.001 0.069 .995
(0.011) (0.0012)
Notes: Esti mates are based on cohort life table data
|
No. of Observations
31
31
31
31
26
26
16
15
Metropolitan Life Insurance Company. The equations estimated are:
log(-log(l - q"^)) = a"^ + |3'^*(t-55) + e"^.
Estimation is by ordinary least squares; standard errors are shown
in parentheses.

